| EN

精準醫學講座系列二

約50名會員參與了本會舉辦的第二場精準醫學講座,探討精準醫學商業發展的機遇及挑戰,以至精準醫學的商業應用。

At the panel discussion, topics such as where Hong Kong is in the development of precision medicine (from research to commercialization), how to facilitate its development progress, and how to gear up support for precision medicine’s commercial applications, etc., were discussed.

Dr. Alexander Chiu (Medical Director, Health and Employee Benefits of AXA Hong Kong and Macau), Dr. Ronald Li (Director & Professor, MWLC for Reparative Medicine, Karolinska Institute Hong Kong), Dr. Daniel Thurley (General Manager, Roche HK Limited), and Prof. Ian Wong (Head of Department of Pharmacology & Pharmacy, The University of Hong Kong) gave refined insights and comments from the perspectives of insurance, R&D, pharmaceutical and big data respectively.

X
Close Bitnami banner
Bitnami